FdaApplication
NDA 022071
Identifiers
- fda_app_no: NDA022071
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2007-09-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMISIL | TERBINAFINE HYDROCHLORIDE | EQ 187.5MG BASE/PACKET | GRANULE;ORAL |
| LAMISIL | TERBINAFINE HYDROCHLORIDE | EQ 125MG BASE/PACKET | GRANULE;ORAL |
2 products